NM_000535.7(PMS2):c.106A>C (p.Ser36Arg) AND Hereditary nonpolyposis colorectal neoplasms

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Oct 17, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000228325.8

Allele description [Variation Report for NM_000535.7(PMS2):c.106A>C (p.Ser36Arg)]

NM_000535.7(PMS2):c.106A>C (p.Ser36Arg)

Gene:

PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7p22.1

Genomic location:

Preferred name:

NM_000535.7(PMS2):c.106A>C (p.Ser36Arg)

HGVS:

NC_000007.14:g.6005949T>G
NG_008466.1:g.8158A>C
NG_050738.1:g.1699T>G
NM_000535.7:c.106A>CMANE SELECT
NM_001322003.2:c.-300A>C
NM_001322004.2:c.-242-1891A>C
NM_001322005.2:c.-300A>C
NM_001322006.2:c.106A>C
NM_001322007.2:c.-110A>C
NM_001322008.2:c.-52-1891A>C
NM_001322009.2:c.-300A>C
NM_001322010.2:c.-242-1891A>C
NM_001322011.2:c.-779A>C
NM_001322012.2:c.-779A>C
NM_001322013.2:c.-300A>C
NM_001322014.2:c.106A>C
NM_001322015.2:c.-379A>C
NP_000526.2:p.Ser36Arg
NP_001308935.1:p.Ser36Arg
NP_001308943.1:p.Ser36Arg
LRG_161t1:c.106A>C
LRG_161:g.8158A>C
NC_000007.13:g.6045580T>G
NM_000535.5:c.106A>C
NM_000535.6:c.106A>C
NR_136154.1:n.193A>C
p.S36R

Protein change:

S36R

Links:

dbSNP: rs587781918

NCBI 1000 Genomes Browser:

rs587781918

Molecular consequence:

NM_001322003.2:c.-300A>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322005.2:c.-300A>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322007.2:c.-110A>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322009.2:c.-300A>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322011.2:c.-779A>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322012.2:c.-779A>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322013.2:c.-300A>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322015.2:c.-379A>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322004.2:c.-242-1891A>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001322008.2:c.-52-1891A>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001322010.2:c.-242-1891A>C - intron variant - [Sequence Ontology: SO:0001627]
NM_000535.7:c.106A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322006.2:c.106A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322014.2:c.106A>C - missense variant - [Sequence Ontology: SO:0001583]
NR_136154.1:n.193A>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Hereditary nonpolyposis colorectal neoplasms
Identifiers:: MeSH: D003123; MedGen: C0009405

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000285042	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Oct 17, 2022)	germline	clinical testing	PubMed (2) [See all records that cite these PMIDs] 28494185, 28492532

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000285042

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Oct 17, 2022)

germline

clinical testing

PubMed (2)
[See all records that cite these PMIDs]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Functional analysis of rare variants in mismatch repair proteins augments results from computation-based predictive methods.

Arora S, Huwe PJ, Sikder R, Shah M, Browne AJ, Lesh R, Nicolas E, Deshpande S, Hall MJ, Dunbrack RL Jr, Golemis EA.

Cancer Biol Ther. 2017 Jul 3;18(7):519-533. doi: 10.1080/15384047.2017.1326439. Epub 2017 May 11.

PubMed [citation]

PMID:: 28494185
PMCID:: PMC5639829

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000285042.7

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (2)

Description

This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 36 of the PMS2 protein (p.Ser36Arg). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PMS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 141660). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PMS2 protein function. Experimental studies have shown that this missense change does not substantially affect PMS2 function (PMID: 28494185). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine